AP521 is a potent agonist of the human 5-HT1A receptor with anxiolytic-like effects; it significantly increases shock acceptance and time spent on open arms in behavioral tests, reduces freezing time, and enhances extracellular serotonin (5-HT) levels in the medial prefrontal cortex (mPFC).